15 Nov 2022 , 02:49 PM
Net profit of Indrayani Biotech rose 405.77% to Rs 5.26 crore in the quarter ended September 2022 as against Rs 1.04 crore during the previous quarter ended September 2021. Sales rose 183.16% to Rs 42.05 crore in the quarter ended September 2022 as against Rs 14.85 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 42.05 | 14.85 | 183 |
| OPM % | 12.37 | 11.04 | – |
| PBDT | 6.01 | 1.15 | 423 |
| PBT | 5.26 | 1.04 | 406 |
| NP | 5.26 | 1.04 | 406 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
